GEODE CAPITAL MANAGEMENT, LLC
Position in VRDN — Viridian Therapeutics, Inc.\DE
CIK 1214717
BOSTON, MA
Position in VRDN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$45,637,645
-$16,358,809 QoQ
Shares Held
2,333,213
+17.1% QoQ
Ownership
2.26%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRDN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GEODE CAPITAL MANAGEMENT, LLC holds $18,583,356,554 across 528 Biotechnology names. VRDN ranks #73 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,139,621 | $2,741,586,360 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,607,732 | $2,014,838,051 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,660,385 | $880,241,584 | |
| 4 | INSM |
INSMED Inc
|
4,450,389 | $727,727,608 | |
| 5 | MRNA |
Moderna, Inc.
|
9,435,132 | $479,304,705 | |
| 6 | INCY |
Incyte Corp
|
4,703,184 | $442,663,677 | |
| 7 | RPRX |
Royalty Pharma plc
|
7,869,632 | $377,506,246 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
4,918,030 | $365,212,906 |
All Filings in VRDN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $45,637,645 | 2,333,213 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $61,996,454 | 1,992,174 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $38,114,315 | 1,766,187 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $24,333,782 | 1,740,614 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $23,192,676 | 1,720,525 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $31,802,646 | 1,658,980 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $33,972,824 | 1,493,311 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $18,361,792 | 1,411,360 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $20,386,402 | 1,164,272 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $21,659,513 | 994,468 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $13,178,517 | 859,095 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $20,479,788 | 860,857 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $19,744,289 | 776,112 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $20,767,871 | 710,985 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $12,301,200 | 599,766 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $5,202,566 | 449,660 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $3,683,910 | 199,238 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $3,987,174 | 201,678 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $1,007,562 | 61,250 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $700,196 | 38,283 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $382,558 | 22,894 | Shares | Defined | 2021-05-12 | |
| No filing history on record for this holder in this stock. | ||||||